ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
24 announcements with these filters
Astonea Labs Ltd reported revenue from operations of ₹50.2 Cr and net profit of ₹3.2 Cr for H2 FY25.
Astonea Labs has resubmitted its standalone financial results for FY25 in PDF format following a BSE query regarding discrepancies in its initial XBRL-only submission.
Promoter Ashish Gulati acquired 14,000 shares of Astonea Labs Ltd from the open market between September 15 and 16, 2026.
Promoter Ashish Gulati acquired 14,000 equity shares of Astonea Labs Ltd via open market transactions between September 15 and 16, 2026.
Astonea Labs Limited appointed Mr. Chander Shekhar as the Internal Auditor. This appointment follows the board meeting held on September 9, 2026.
Astonea Labs held a board meeting, appointing an internal auditor, incorporating a subsidiary, investing USD 10,000 in a US subsidiary, and terminating certain business agreements.
Astonea Labs Limited has re-appointed Ms. Pooja Singh as an Executive Director effective August 21, 2026. This change in leadership was disclosed to the BSE.
Astonea Labs Limited held its 9th Annual General Meeting on August 21, 2026. Shareholders considered and voted on various ordinary and special resolutions.
Astonea Labs Limited has submitted its Annual Report for the financial year ended March 31, 2026. The report includes the notice convening the company's 9th Annual General Meeting.
Astonea Labs Limited has issued the notice for its 9th Annual General Meeting scheduled for August 21, 2026. The meeting will address ordinary and special business resolutions.
Astonea Labs amended a board resolution from May 2026 to update statutory references, conforming to the Income-tax Act, 2025 for the existing tax auditor appointment.
Astonea Labs amended a board resolution from May 30, 2026, to align the Tax Auditor's appointment with the provisions of the Income Tax Act, 2025.
Astonea Labs Ltd will hold a board meeting on July 24, 2026, to consider audited consolidated financial results, the annual report, and other corporate matters.
Astonea Labs sold two commercial units in Gurugram for Rs. 2.99 Crore. The transaction aims to monetize assets and optimize the company's portfolio.
Astonea Labs successfully completed a manufacturing facility inspection by Yemen's SBDMA. The company received the official certificate today confirming regulatory compliance for its Haryana plant.
Astonea Labs Limited submitted its Related Party Transactions disclosure for the half-year ended March 31, 2026. Total transactions during the period amounted to ₹32.04 Crore.
Astonea Labs Limited reported a reallocation of ₹37.67 Crore in IPO proceeds. The funds were redirected towards acquiring an equity stake in Damaira Pharmaceuticals Private Limited.
Astonea Labs Limited re-appointed Mr. Sahil Malhotra as Secretarial Auditor for FY 2026-27. The move ensures continued regulatory compliance and statutory secretarial auditing for the company.
Astonea Labs Ltd reported revenue from operations of ₹81.3 Cr and net profit of ₹3.1 Cr for H2 FY26.
Astonea Labs approved FY26 standalone audited results and a ₹34 Crore Related Party Transaction limit. The board also terminated a manufacturing and brand license agreement.
Astonea Labs Ltd scheduled a board meeting for May 30, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-announcement.
Astonea Labs Ltd confirmed it does not qualify as a 'Large Corporate' as per SEBI criteria for the financial year ended March 31, 2026. The company reported outstanding borrowings of ₹23.96 Crore, which is below the regulatory threshold for large corporate identification. This is a routine regulatory compliance disclosure.
Astonea Labs Ltd reported a fire incident at its Panchkula manufacturing facility on April 27, 2026. No casualties occurred, but production is temporarily suspended for an estimated 90 days for restoration. The incident is covered by insurance, and the company is currently assessing the total financial impact.
Astonea Labs Ltd submitted its investor grievance report for the quarter ended March 31, 2026. The company reported zero pending, received, or unresolved complaints during the period. The report was issued in compliance with SEBI Listing Obligations and Disclosure Requirements.